Marketing Consultants to the Overlooked Disabled Community

NEW YORK - HealthDay News noted 37 of 120 people with a severe fungal eye infection linked to a Bausch & Lomb contact lens solution have had corneal transplants, it was reported.  That's 31% of Fusarium keratitis cases studied by the U.S. Centers for Disease Control and Prevention (CDC) - eight transplants had been reported by CDC earlier.  "You're going to see a higher percentage of these patients needing a transplant," said Dr. Robert Cykiert, clinical associate professor of ophthalmology at New York University School of Medicine.  "The reason is when we diagnose fungal infection, we try to treat it with eye drops, [and] oral medications."  In general, about half of people who contract fungal corneal infections will require transplants, he said.  Some patients who respond to medication get scarring of the cornea.  They will need transplants.  Bausch removed that solution, ReNu with MoistureLoc, from the market on May 15.  It stopped sales of the product on April 13, following reports of an unusually high number of fungal infections in users of the product.  Some 30 million Americans wear contact lenses, and about 2.3 million used MoistureLoc, the Associated Press stated.  Bausch also makes ReNu MultiPlus, ReNu Multi-Purpose, and generic brands.  While the MultiPlus and Multi-Purpose solutions seem not to be implicated, it's unclear if any generic solutions (such as those for WalMart) are unsafe.